Newest Release of Price Rx Includes NADAC Pricing Information and Additional User Enhancements

Tuesday, January 28, 2014

Indiana, Indianapolis —(January 28, 2014) — Wolters Kluwer Health , a leading global provider of information for healthcare professionals and students, announced today that Price Rx® v2.2 now features NADAC pricing information and several other key enhancements, helping to save users valuable time in research and reporting for selected drug products.

Price Rx customers now have the ability to quickly reference the National Average Drug Acquisition Cost
(NADAC), the newly published national pricing benchmark from the Centers for Medicaid and Medicare Services (CMS), directly from within the Price Rx application for a given drug product. This information is fueled by data from the Medi-Span® Federal Government Pricing File™, which identifies similar NDCs not reported by CMS and extrapolates NADAC pricing to these NDCs. On average, for every NDC CMS reports, Medi-Span extrapolates to an additional 1-2 NDCs; such NDCS are readily identified and distinguished from the CMS-based NDCs.

“Price Rx is the only pricing analysis tool that provides both NADAC pricing and the extrapolated Medi-Span data,” stated David Del Toro, Vice President & General Manager, Clinical Drug Information, Wolters Kluwer Health, Clinical Solutions. “As a result, Price Rx provides a more robust picture of NADAC pricing for affected NDCs as reported by Medi-Span, helping our customers with a variety of business needs.”

Additional key enhancements in this release that focus on improving the user experience include more powerful custom reporting, streamlines email alert messaging, more flexible Product Name search, and better organization of reports with the ability to select those as “Favorites.”